BackCOSMOS Pharmaceutical Overview

COSMOS Pharmaceutical Current Cash

Track COSMOS Pharmaceutical's current cash ($61B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$61.34B
↑ 7.54% YoYΔ $4.30B vs prior year quarter

Peer trimmed avg / median

Loading

COSMOS Pharmaceutical Current Cash History

Loading

COSMOS Pharmaceutical vs. peers: Current Cash Comparison

Loading

COSMOS Pharmaceutical Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

COSMOS Pharmaceutical (CSMYF) FAQ

COSMOS Pharmaceutical (CSMYF) currently reports a current cash of $61B as of May 2026. That compares with $57B in the prior-year period — up 7.5% year over year. Use the charts on this page to explore COSMOS Pharmaceutical's current cash history and peer comparisons.

COSMOS Pharmaceutical's current cash increased from $57B to $61B — a 7.5% year-over-year increase (period ending May 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

COSMOS Pharmaceutical reported $61B in current cash as of May 2026. That compares with $57B in the prior-year period — up 7.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $61B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for COSMOS Pharmaceutical, and consider following CSMYF for alerts when major investors trade the stock.